About this item:

115 Views | 39 Downloads

Author Notes:

Ravi Mehrotra, MD, DPhil, Chip Foundation, 361, Sect 15A, Noida, 201301 India; Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322; E-mail: ravi.mehrotra@gov.in

Conception and Design: Kavita Yadav, Ian Cree, Andrew Field, Ravi Mehrotra Collection and assembly of data: Andrew Field, Philippe Vielh Data analysis and interpretation: Ian Cree, Andrew Field, Philippe Vielh Manuscript writing: All authors Final approval of manuscript: All authors Accountable for all aspects of the work: All authors

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/authors/author-center. Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments). No potential conflicts of interest were reported.

Subjects:

Keywords:

  • SARS-CoV-2
  • FNAB

Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries

Tools:

Journal Title:

Jco Global Oncology

Volume:

Volume 8

Publisher:

Type of Work:

Article | Post-print: After Peer Review

Abstract:

The rising cancer burden in low- and middle-income countries (LMICs) stresses already weak health care systems and poses unique challenges. In resource-constrained LMICs and in circumstances where most patients must pay out of pocket for diagnostic tests, these may not be available or affordable for many. Cytopathology provides a simple, inexpensive, standardized, and low-technology diagnostic procedure that is increasingly used as an effective tool to address the hurdles faced in cancer control programs in LMICs. This review explores the potential role of cytopathology in LMICs in reducing the cancer burden.

Copyright information:

© 2022 by American Society of Clinical Oncology

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/rdf).
Export to EndNote